Histone acylations and chromatin dynamics: concepts, challenges, and links to metabolism S Nitsch, L Zorro Shahidian, R Schneider EMBO reports 22 (7), e52774, 2021 | 104 | 2021 |
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells T Mlambo, S Nitsch, M Hildenbeutel, M Romito, M Müller, C Bossen, ... Nucleic acids research 46 (9), 4456-4468, 2018 | 98 | 2018 |
Succinylation of H3K122 destabilizes nucleosomes and enhances transcription L Zorro Shahidian, M Haas, S Le Gras, S Nitsch, A Mourão, A Geerlof, ... EMBO reports 22 (3), e51009, 2021 | 50 | 2021 |
Loss of maternal Trim28 causes male-predominant early embryonic lethality AS Kumar, MKY Seah, KY Ling, Y Wang, JHL Tan, S Nitsch, SL Lim, ... Genes & development 31 (1), 12-17, 2017 | 30 | 2017 |
Generation of TALE-based designer epigenome modifiers S Nitsch, C Mussolino Epigenome editing: methods and protocols, 89-109, 2018 | 9 | 2018 |
Impact of cryopreservation on histone modifications of mesenchymal stem cells S Nitsch, A Chatterjee, N Hofmann, B Glasmacher Biomedizinische Technik 59, S294-7, 2014 | 5 | 2014 |
Construct for epigenetic modification and its use in the silencing of genes T Cathomen, C Mussolino, TI Cornu, T Mlambo, S Nitsch, J Alzubi, ... US Patent 11,072,782, 2021 | 2 | 2021 |
Construct for epigenetic modification and its use in the silencing of genes T Cathomen, C Mussolino, TI Cornu, T Mlambo, S Nitsch, J Alzubi, ... US Patent App. 15/657,641, 2019 | 1 | 2019 |
Native ChIP: Studying the Genome-Wide Distribution of Histone Modifications in Cells and Tissue S Nitsch, R Schneider Methods in molecular biology (Clifton, NJ) 2846, 1-16, 2024 | | 2024 |
A novel designer epigenome modifier platform enables robust and sustained gene silencing in clinically relevant human cells T Mlambo, S Nitsch, M Hildenbeutel, M Romito, C Bossen, TI Cornu, ... HUMAN GENE THERAPY 28 (12), A15-A15, 2017 | | 2017 |